86 related articles for article (PubMed ID: 25232917)
21. MDR1 gene polymorphisms and acute myeloid leukemia AML susceptibility in A Moroccan adult population: A case-control study and meta-analysis.
Kaltoum ABO; Sellama N; Hind D; Yaya K; Mouna L; Asma Q
Curr Res Transl Med; 2020 Jan; 68(1):29-35. PubMed ID: 31307954
[TBL] [Abstract][Full Text] [Related]
22. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
[TBL] [Abstract][Full Text] [Related]
23. Germline polymorphism of p53 codon 72 in gynecological cancer.
Ueda M; Terai Y; Kanda K; Kanemura M; Takehara M; Yamaguchi H; Nishiyama K; Yasuda M; Ueki M
Gynecol Oncol; 2006 Jan; 100(1):173-8. PubMed ID: 16168468
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between RAD51-g135C and XRCC3-C241T polymorphisms and prognosis of inv (16)/ t(16;16) (CBFbeta-MYH11) acute myeloid leukemia].
Liu L; Yang L; Mi YC; Li JY; Qin TJ; Xu ZF; Zhang Y; Wang JX; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):433-8. PubMed ID: 22213860
[TBL] [Abstract][Full Text] [Related]
25. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.
Jakobsen Falk I; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
Br J Haematol; 2014 Dec; 167(5):671-80. PubMed ID: 25155901
[TBL] [Abstract][Full Text] [Related]
26. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
27. Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan.
Wu MT; Chen MC; Wu DC
Cancer Lett; 2004 Mar; 205(1):61-8. PubMed ID: 15036662
[TBL] [Abstract][Full Text] [Related]
28. [Heterogeneity of acute myeloid leukemia with the translocation t(8;21)(q22;q22)].
Gritsaev SV; Martynkevich IS; Ziuzgin IS; Kariagina EV; Martynenko LS; Petrova EV; Tsybakova NIu; Ivanova MP; Kostroma II; Tiranova SA; Potikhonova NA; Abdulkadyrov KM
Ter Arkh; 2014; 86(7):45-52. PubMed ID: 25314777
[TBL] [Abstract][Full Text] [Related]
29. IL-10 promoter polymorphisms affect IL-10 production and associate with susceptibility to acute myeloid leukemia.
Chenjiao Y; Zili F; Haibin C; Ying L; Sheng X; Lihua H; Wei D
Pharmazie; 2013 Mar; 68(3):201-6. PubMed ID: 23556339
[TBL] [Abstract][Full Text] [Related]
30. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
[TBL] [Abstract][Full Text] [Related]
31. [Relationships between the gene polymorphisms of drug metabolizing enzymes and the outcome of the first induction chemotherapy in patients with de novo acute myeloid leukemia].
Wang N; Han JL; Mi YC; Xiao ZJ; Feng SZ; Zhou YL; Wang JX; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):327-31. PubMed ID: 21518482
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of TP53 mutations and single nucleotide polymorphisms in acute myeloid leukemia: a case series and literature review.
Zeichner SB; Alghamdi S; Elhammady G; Poppiti RJ
Asian Pac J Cancer Prev; 2014; 15(4):1603-9. PubMed ID: 24641375
[TBL] [Abstract][Full Text] [Related]
33. Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia.
Nakano Y; Naoe T; Kiyoi H; Kunishima S; Minami S; Miyawaki S; Asou N; Kuriyama K; Saito H; Ohno R
Leuk Res; 2000 Apr; 24(4):349-52. PubMed ID: 10713332
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease.
Lee YL; Chen W; Tsai WK; Lee JC; Chiou HL; Shih CM; Wang YC
J Lab Clin Med; 2006 May; 147(5):228-33. PubMed ID: 16697770
[TBL] [Abstract][Full Text] [Related]
35. Multidrug-related protein 1 (MRP1) polymorphisms rs129081, rs212090, and rs212091 predict survival in normal karyotype acute myeloid leukemia.
Kunadt D; Dransfeld C; Dill C; Schmiedgen M; Kramer M; Altmann H; Röllig C; Bornhäuser M; Mahlknecht U; Schaich M; Stölzel F
Ann Hematol; 2020 Sep; 99(9):2173-2180. PubMed ID: 32621177
[TBL] [Abstract][Full Text] [Related]
36. MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Phillips CL; Gerbing R; Alonzo T; Perentesis JP; Harley IT; Meshinchi S; Bhatla D; Radloff G; Davies SM
Pediatr Blood Cancer; 2010 Aug; 55(2):248-53. PubMed ID: 20582981
[TBL] [Abstract][Full Text] [Related]
37. MCM7 polymorphisms associated with the AML relapse and overall survival.
Lee JS; Cheong HS; Koh Y; Ahn KS; Shin HD; Yoon SS
Ann Hematol; 2017 Jan; 96(1):93-98. PubMed ID: 27837251
[TBL] [Abstract][Full Text] [Related]
38. Association between p53 codon 72 polymorphisms and clinical outcome of nasopharyngeal carcinoma.
Li ML; Dong Y; Hao YZ; Xu N; Ning FL; Chen SS; Yu JM
Genet Mol Res; 2014 Dec; 13(4):10883-90. PubMed ID: 25526208
[TBL] [Abstract][Full Text] [Related]
39. Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.
Yee SW; Mefford JA; Singh N; Percival ME; Stecula A; Yang K; Witte JS; Takahashi A; Kubo M; Matsuda K; Giacomini KM; Andreadis C
J Hum Genet; 2013 Jun; 58(6):353-61. PubMed ID: 23677058
[TBL] [Abstract][Full Text] [Related]
40. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
